文献速递慢性肾脏病

尿-血浆尿素比值与慢性肾脏病进展的关联

Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
PubMed 文献 · Am J Kidney Dis · 2022-11-07

在美国慢性肾功能不全队列(CRIC)的3723例成人CKD患者中,基线尿-血浆尿素比值中位数为14.8(IQR 9.5-22.2)。随访7.0(IQR 3.0-11.0)年期间,该比值最低五分位组较高五分位组eGFR下降更快,每年多下降1.06 mL/min/1.73 m2(P<0.001);自然对数转换后该比值每降低1个标准差,CKD进展风险HR为1.22(95%CI 1.12-1.33),启动肾脏替代治疗风险HR为1.22(95%CI 1.10-1.33)。基线eGFR<30 mL/min/1.73 m2者中该关联不显著。

要点

  • 尿-血浆尿素比值最低五分位组较高五分位组eGFR每年多下降1.06 mL/min/1.73 m2(P<0.001)。
  • 自然对数转换后该比值每降低1个标准差,CKD进展HR为1.22(95%CI 1.12-1.33)。
  • 基线eGFR<30 mL/min/1.73 m2者中该比值与CKD进展的关联不显著(HR 1.00,95%CI 0.84-1.20)。

核心结论

  • 在大型多样化常见CKD患者队列中,尿-血浆尿素比值与疾病进展及新发肾衰竭独立相关。
  • 基线即为晚期CKD者中该关联不显著。

研究设计与样本

  • 观察性队列研究。
  • 纳入美国慢性肾功能不全队列(CRIC)中3723例eGFR 20-70 mL/min/1.73 m2的成人。
  • 暴露为基线24小时尿液与血浆样本计算的尿-血浆尿素比值。
  • 采用多变量线性混合效应模型检验与eGFR斜率的关联,Cox比例风险模型检验与二分类CKD结局的关联。

主要发现

  • 尿-血浆尿素比值中位数为14.8(IQR 9.5-22.2)。
  • 随访7.0(IQR 3.0-11.0)年期间,最低五分位组较高五分位组eGFR每年多下降1.06 mL/min/1.73 m2(P<0.001)。
  • 自然对数转换后该比值每降低1个标准差,CKD进展风险HR为1.22(95%CI 1.12-1.33),启动肾脏替代治疗风险HR为1.22(95%CI 1.10-1.33)。
  • 关联因基线eGFR不同而异(交互作用P=0.009):eGFR≥30 mL/min/1.73 m2者中每降低1个标准差CKD进展HR为1.30(95%CI 1.18-1.45),eGFR<30 mL/min/1.73 m2者中HR为1.00(95%CI 0.84-1.20),不显著。

局限性

  • 可能存在残余混杂。
  • 尿-血浆尿素比值仅基于单次基线24小时尿液采集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVES: The urine-to-plasma (U/P) ratio of urea is correlated with urine-concentrating capacity and associated with progression of autosomal dominant polycystic kidney disease. As a proposed biomarker of tubular function, we hypothesized that the U/P urea ratio would also be associated with progression of more common forms of chronic kidney disease (CKD). STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 3,723 adults in the United States with estimated glomerular filtration rate (eGFR) of 20-70 mL/min/1.73 m2, enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study. EXPOSURE: U/P urea ratio, calculated from 24-hour urine collections and plasma samples at baseline. OUTCOME: Associations of U/P urea ratio with eGFR slope, initiation of kidney replacement therapy (KRT), and CKD progression, defined as 50% decline in eGFR or incident KRT. ANALYTICAL APPROACH: Multivariable linear mixed-effects models tested associations with eGFR slope. Cox proportional hazards models tested associations with dichotomous CKD outcomes. RESULTS: The median U/P urea ratio was 14.8 (IQR, 9.5-22.2). Compared with participants in the highest U/P urea ratio quintile, those in the lowest quintile had a greater eGFR decline by 1.06 mL/min/1.73 m2 per year (P < 0.001) over 7.0 (IQR, 3.0-11.0) years of follow-up observation. Each 1-SD lower natural log-transformed U/P urea ratio was independently associated with CKD progression (HR, 1.22 [95% CI, 1.12-1.33]) and incident KRT (HR, 1.22 [95% CI, 1.10-1.33]). Associations differed by baseline eGFR (P interaction = 0.009). Among those with an eGFR ≥30 mL/min/1.73 m2, each 1-SD lower in ln(U/P urea ratio) was independently associated with CKD progression (HR, 1.30 [95% CI, 1.18-1.45]), but this was not significant among those with eGFR <30 mL/min/1.73 m2 (HR, 1.00 [95% CI, 0.84-1.20]). LIMITATIONS: Possibility of residual confounding. Single baseline 24-hour urine collection for U/P urea ratio. CONCLUSIONS: In a large and diverse cohort of patients with common forms of CKD, U/P urea was independently associated with disease progression and incident kidney failure. Associations were not significant among those with advanced CKD at baseline.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Liu J, Bankir L, Verma A, et al. Association of the Urine-to-Plasma Urea Ratio With CKD Progression. Am J Kidney Dis. 2022. PMID: 36356680. doi:10.1053/j.ajkd.2022.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。